Lysine-Specific Demethylase 1 (LSD1) Inhibitors: Peptides as an Emerging Class of Therapeutics
ACS Chemical Biology · 2023
DOI: 10.1021/acschembio.3c00386 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Chemical Biology, 2023. Verfasst von Stephin Baby und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, Gujarat 380054, India. Hauptthemen laut MEDLINE: Enzyme Inhibitors, Histone Demethylases, Peptides, Benzamides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 90 Literaturangaben. Gefördert von: National Institute of Pharmaceutical Education and Research, Ahmedabad, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, Gujarat 380054, India.
ORCID-Profile: Bichismita Sahu
Förderung
- National Institute of Pharmaceutical Education and Research, Ahmedabad
- Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
Zitieren
APA
Baby, S., Shinde, S. D., Kulkarni, N., & Sahu, B. (2023). Lysine-Specific Demethylase 1 (LSD1) Inhibitors: Peptides as an Emerging Class of Therapeutics. ACS Chemical Biology. https://doi.org/10.1021/acschembio.3c00386
Vancouver
Baby S, Shinde SD, Kulkarni N, Sahu B. Lysine-Specific Demethylase 1 (LSD1) Inhibitors: Peptides as an Emerging Class of Therapeutics. ACS Chemical Biology. 2023. doi:10.1021/acschembio.3c00386
BibTeX
@article{Baby2023,
author = {Baby, Stephin and Shinde, Suchita Dattatray and Kulkarni, Neeraj and Sahu, Bichismita},
title = {Lysine-Specific Demethylase 1 (LSD1) Inhibitors: Peptides as an Emerging Class of Therapeutics},
journal = {ACS Chemical Biology},
year = {2023},
doi = {10.1021/acschembio.3c00386}
}
EUVIMED